26
Participants
Start Date
March 6, 2015
Primary Completion Date
January 14, 2020
Study Completion Date
January 14, 2020
Robotic Assisted Radical Prostatectomy
Undergo RARP
Conventional open retropubic radical prostectomy
Undergo conventional open RRP
Laboratory Biomarker Analysis
Correlative studies
Quality-of-Life Assessment
Ancillary studies
ADT (androgen deprivation therapy) (i.e. leuprolide) plus an androgen receptor inhibitor (i.e. bicalutamide)
LHRH agonist or antagonist (i.e. leuprolide) plus an androgen receptor inhibitor (i.e. bicalutamide)
City of Hope National Medical Center (COH), Duarte
University of California, Irvine (UCI), Orange
Rutgers Cancer Institute of New Jersey, New Brunswick
National Cancer Institute (NCI)
NIH
Rutgers Cancer Institute of New Jersey
OTHER
Rutgers, The State University of New Jersey
OTHER